Although still considered a “rare” disease in the context of a population-based incidence of approximately 0.5 per 10,000 children per year [1], pulmonary embolism (PE) is nevertheless an important and… Click to show full abstract
Although still considered a “rare” disease in the context of a population-based incidence of approximately 0.5 per 10,000 children per year [1], pulmonary embolism (PE) is nevertheless an important and increasingly recognized condition in pediatrics, with substantive risks of mortality and morbidity [2,3]. Unfortunately, these risks and numerous other critical factors regarding pediatric PE have historically been poorly characterized. In order to advance knowledge on pediatric PE, the Pediatric and Neonatal This article is protected by copyright. All rights reserved.
               
Click one of the above tabs to view related content.